The stock prices of three pharmaceutical companies heavily involved in vaccine production fell drastically by market close on Thursday, November 14, 2024. This decline followed President-elect Donald Trump's announcement that he was appointing Robert F Kennedy Jr. to head the Department of Health and Human Services (HHS).